King Olav V's cancer research prize for 2016 goes to Kjetil Taskén. He receives the award for his outstanding work in the field of immunotherapy.
The award will be handed over by HM King Harald V on behalf of the Norwegian Cancer Society in Oslo June 6th. The prestigious prize is distributed annually by the Norwegian Cancer Society, and the winner receives NOK 1.000.000.
Taskén has been Director of the Centre for Molecular Medicine Norway (NCMM) since 2009 and Director of the Biotechnology Centre of Oslo since 2003. He also has a position as a senior researcher at the Department of Infectious Diseases at the Division of Medicine, Oslo University Hospital.
Articles in Norwegian:
Press release from the Norwegian Cancer Society - Professor Kjetil Taskén ved Universitetet i Oslo tildeles Kong Olav Vs kreftforskningspris 2016.
News article from the UiO home page - Kjetil Tasken får Kong Olav Vs kreftforskningspris
Taskén Group home pages:
At The Biotechnology Centre of Oslo:
Signal transduction in health and disease: the role of cAMP signalling pathways.
At Centre for Molecular Medicine Norway:
Signalling Networks in Health and Disease